Topics

Arsenal of Targeted Therapies Slated to Expand in NSCLC

14:45 EDT 15 Aug 2019 | OncLive

Badi El-Osta, MD, discusses the targeted agents that are showing the most promise for patients with non–small cell lung cancer who have rare alterations and variants.

Original Article: Arsenal of Targeted Therapies Slated to Expand in NSCLC

NEXT ARTICLE

More From BioPortfolio on "Arsenal of Targeted Therapies Slated to Expand in NSCLC"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...